Results 201 to 210 of about 45,661 (289)

The role of circRNAs in resistance to doxorubicin

open access: yesCell Communication and Signaling
Doxorubicin is an anthracyline recognized as an antitumor antibiotic agent. It is widely used in the chemotherapeutic regimens in different types of cancers. Resistance to doxorubicin is a major clinical obstacle and main cause of failure in cancer chemotherapy.
Mahla Sanati, Soudeh Ghafouri-Fard
openaire   +3 more sources

Identification of circRNA biomarkers in osteosarcoma: An updated systematic review and meta-analysis [PDF]

open access: yes
Circular RNAs (circRNAs) play a crucial role in cancer development and progression. This study aimed to identify potential circRNA biomarkers for osteosarcoma. Articles published from January 2010 to September 2023 were searched across eight databases to
Balmer, Lois   +6 more
core   +2 more sources

Differential Expressions of circRNAs and Regulatory Mechanisms of ceRNA Network in Liver of Wilson’s Disease TX Mice

open access: yesJournal of Inflammation Research
Hong Chen,* Xie Wang,* Nian Peng, Yue Pu, Hao Ye, Yu Gui, Rui Zhang, Juan Zhang Department of Neurology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, 230031, People’s Republic of China*These ...
Chen H   +7 more
doaj  

Targeted Therapies in the Most Common Advanced Solid Tumors, Drug Resistance, and Counteracting Progressive Micrometastatic Disease: The Next Frontier of Research

open access: yesMedComm, Volume 6, Issue 10, October 2025.
In TME, undetectable DCCs (panel A) join with a low tumor burden along with low immune suppression, that favor successful immune manipulation through immune suppression inhibiting immune‐therapy. This moves the immune balance toward the immune response and likely makes more stable the dormant state of DCCs in the unstable metastatic niche and/or allows
Andrea Nicolini   +3 more
wiley   +1 more source

Hypertrophic Scarring and Keloids: Epidemiology, Molecular Pathogenesis, and Therapeutic Interventions

open access: yesMedComm, Volume 6, Issue 10, October 2025.
Hypertrophic scars and keloids highlight distinct epidemiology, multifactorial triggers (genetic, mechanical, medical), and dysregulated signaling hubs (TGF‐β, Integrin‐FAK, Wnt/β‐catenin). Emerging interventions targeting fibroblast plasticity, inflammation, and biomechanics via gene editing, immune modulation, and biomaterials are increasingly ...
Xiaowan Fang   +7 more
wiley   +1 more source

Heart Regeneration and Repair: Molecular Mechanism and Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 10, October 2025.
Regarding the general picture of heart regeneration therapy, it encompasses exogenous cell therapy, endogenous medications, metabolism, interventions in gene pathways, as well as the therapeutic strategies in the burgeoning interdisciplinary field of medicine and engineering in recent years.
Mingchuan Liu   +9 more
wiley   +1 more source

CircCDYL Association With hnRNPL Modulates CDYL Isoform Switching in Breast Cancer Cells

open access: yesCancer Science, Volume 116, Issue 10, Page 2750-2762, October 2025.
We investigated the synergic role of the circRNA circCDYL and the splicing factor hnRNPL in modulating alternative splicing and isoform switch in breast cancer cells, with a focus on circCDYL and hnRNPL‐mediated isoform switch events involving the CDYL gene.
Serena Bernardi   +11 more
wiley   +1 more source

Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application

open access: yesThe FEBS Journal, Volume 292, Issue 19, Page 4979-4991, October 2025.
Multiple myeloma is characterised by the clonal proliferation of plasma cells in the bone marrow. Extracellular vesicles (EVs) are a key component of cell‐to‐cell communication within the bone marrow microenvironment, promoting tumour growth, bone remodelling, immune modulation, angiogenesis and therapeutic resistance.
Chloe Wylie   +3 more
wiley   +1 more source

Circ_0008146 Exacerbates Ferroptosis via Regulating the miR-342-5p/ACSL4 Axis After Cerebral Ischemic/Reperfusion

open access: yesJournal of Inflammation Research
Cai-Dong Liu,1,2,* Qiang Peng,3,* Shi-Yao Wang,3,* Yang Deng,2 Zhong-Yuan Li,3 Zhao-Han Xu,3 Liang Wu,3 Ying-Dong Zhang,2,3 Rui Duan3 1Department of Laboratory Medicine, Nanjing First Hospital, China Pharmaceutical University, Nanjing ...
Liu CD   +8 more
doaj  

Home - About - Disclaimer - Privacy